Objective COVID-19 due to SARS-CoV-2 virus is a new cause of severe acute respiratory
syndrome (SARS). Little is known about the short-term cognitive prognosis for these …

The exact incidence of neurological and cognitive sequelae of COVID-19 in the long term is
yet unknown. The aim of this research is to investigate the type of neurological and cognitive …

Objective: The aim was to conduct a review on the literature on objective cognitive
impairment in patients after COVID-19. Methods: We performed a literature review and …

Background Cognitive manifestations associated with Severe Acute Respiratory Syndrome
by Coronavirus 2 (SARS-CoV-2) are yet to be described in the existing literature. The aim of …

Background and purpose Cognitive dysfunction has been observed following recovery from
COVID‐19. To the best of our knowledge, however, no study has assessed the progression …

Purpose Intensive care unit (ICU) survivors can experience wide-ranging and long-lasting
symptoms after hospital discharge. Cognitive impairment has received increased attention in …

Background Subjective and objective cognitive dysfunction are reported after COVID-19 but
with limited data on their congruence and associations with the severity of the acute disease …

This meta-analysis was conducted to quantify the risk of patients exhibiting cognitive deficits
in the acute phase of COVID-19 at the time of the first variants (ie, before the vaccine) and …

Purpose To screen the neurocognitive impairment persistent post-COVID-19. Patients and
Methods We assessed the neuropsychiatric disorders associated with COVID-19 in a …

Objective Quantify cognitive deficits in patients with postacute sequelae of COVID-19
(PASC) and identify key variables related to cognitive impairment in PASC. Method Patients …